Author

Luca Magnani

Institute of Cancer ResearchORCID 0000-0002-7534-0785Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Adam Stewart· 1 shared Ahmet AcariD· 1 shared Alexander Wilkes· 1 shared Almut SchulzeiD· 1 shared An-Jie Ler· 1 shared Andrea SottorivaiD· 1 shared Angelika Wörner· 1 shared Anthony J. DevliniD· 1 shared

Activity by Year

2019-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 9 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam Stewart

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cancer BiologyClinical EpigeneticsPeer-reviewedApr 29, 2026

GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer

Janina Müller, Emre Sofyalı, Luisa E. Schwarzmüller…·Stefan Wiemann

This study identifies GLYATL1 as a mediator of endocrine resistance in luminal breast cancer by promoting metabolic and epigenetic changes that counteract estrogen deprivation.

3 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 11, 2026

X-CODE: a dual RNA barcoding system for multi-platform clonal tracking and spatial phenotyping

Roberto Rota, Elizabeth Flittner, Matteo Tartagni…·Marco Bezzi

X-CODE enables multi-platform clonal tracking and spatial phenotyping by combining RNA barcoding with sequencing and imaging technologies.

DOI 10.64898/2026.02.10.705126

humanspatial transcriptomics

𝕏 PostBluesky

Cell BiologyNature CommunicationsPeer-reviewedDec 9, 2025

Chemically modified CRISPR-Cas9 enables targeting of individual G-quadruplex and i-motif structures, revealing ligand-dependent transcriptional perturbation.

Sabrina Pia Nuccio, Enrico Cadoni, Roxani Nikoloudaki…·Marco Di Antonio

This paper introduces ATENA, a method using chemically modified CRISPR-Cas9 to target specific G-quadruplexes and i-motifs, showing ligand-dependent transcriptional changes in c-MYC.

22 citationstop 2%

humanDNA methylation

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 4, 2019

Exploiting evolutionary herding to control drug resistance in cancer

Ahmet Acar, Daniel Nichol, Javier Fernandez-Mateos…·Andrea Sottoriva

This paper demonstrates evolutionary herding in non-small cell lung cancer to control drug resistance by shifting clonal composition and inducing collateral sensitivity.

DOI 10.1101/566950

humanscRNA-seq

𝕏 PostBluesky